Trending...
- Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 192
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- On the Boards: Proform Builds Announce New Construction in Alki, Seattle
NEW YORK, Jan. 28, 2025 ~ The Ovarian Cancer Research Alliance (OCRA), the world's largest gynecologic cancer nonprofit, has announced a significant collaboration with the Rivkin Center for Ovarian Cancer Research, effective April 1, 2025. This partnership brings together two highly respected organizations with a shared goal of advancing research for a cure for ovarian cancer.
OCRA will be building upon the Rivkin Center's impressive legacy of funding innovative ovarian cancer research and providing crucial resources to the Pacific Northwest community. This integration will also allow OCRA to expand its reach nationally and globally, ensuring that education, support, and scientific advancements are accessible to the entire ovarian cancer community.
Audra Moran, President and CEO of OCRA, expressed her admiration for the Rivkin Center's contributions in advancing ovarian cancer research and connecting with the community. She believes that this collaboration will create a stronger foundation to support patients and families while honoring Dr. Saul Rivkin's remarkable legacy and driving progress in research.
More on Washingtoner
This announcement comes just one month after The Clearity Foundation joined forces with OCRA, making it the largest organization dedicated to fighting gynecologic cancers in the world. Moran sees these partnerships as a significant step forward in their mission to accelerate research, improve patient care, and create a more cohesive network for those affected by ovarian cancer.
Since its establishment in 1996, the Rivkin Center has been at the forefront of ovarian cancer research. It has provided essential seed-funding grants that have led to groundbreaking discoveries and hosted the biennial Ovarian Cancer Research Symposium in partnership with the American Association of Cancer Research (AACR). Under OCRA's leadership, these signature programs will continue with grants and symposiums renamed to honor Dr. Rivkin's enduring contributions to the field.
Dr. Saul Rivkin, retired oncologist and founder of the Rivkin Center, expressed his confidence in OCRA as an aligned partner to carry forward their vision and amplify their efforts. He believes that this partnership will ensure the growth and success of their investments in research and relationships with the community, bringing them closer to a cure. Dr. Rivkin and his family fully support this exciting new chapter.
More on Washingtoner
Melissa Rivkin, current board president of the Rivkin Center, will join OCRA's Board of Directors, while Dr. Jackie Lang, director of Scientific Programs at the Rivkin Center, will play a crucial role in OCRA's engagement with the scientific community.
OCRA is committed to continuing beloved Rivkin Center initiatives such as the annual SummeRun for Ovarian Cancer, which will take place on July 13, 2025, in Seattle. Dr. Rivkin will be present at the finish line as always.
More details about the combined programs and services will be shared in the coming months. Both OCRA and the Rivkin Center are dedicated to ensuring a seamless transition that honors the legacy of the Rivkin Center while strengthening support for patients, researchers, and the broader ovarian cancer community.
OCRA will be building upon the Rivkin Center's impressive legacy of funding innovative ovarian cancer research and providing crucial resources to the Pacific Northwest community. This integration will also allow OCRA to expand its reach nationally and globally, ensuring that education, support, and scientific advancements are accessible to the entire ovarian cancer community.
Audra Moran, President and CEO of OCRA, expressed her admiration for the Rivkin Center's contributions in advancing ovarian cancer research and connecting with the community. She believes that this collaboration will create a stronger foundation to support patients and families while honoring Dr. Saul Rivkin's remarkable legacy and driving progress in research.
More on Washingtoner
- Longevity Leaders Project to Feature Hunter Ziesing of Global Health Atlas
- Spokane: SPD Arrest Male Suspected of Burglarizing Home in the Evacuation Zone
- Tacoma: Update Third Homicide Arrest – 2100 block of N 30th St
- Slotozilla Reports Strong Growth in Q2 2026
- Why U.S. Enterprises Are Replacing Fragmented eCommerce Stacks with AI Driven Platform Like Diginyze
This announcement comes just one month after The Clearity Foundation joined forces with OCRA, making it the largest organization dedicated to fighting gynecologic cancers in the world. Moran sees these partnerships as a significant step forward in their mission to accelerate research, improve patient care, and create a more cohesive network for those affected by ovarian cancer.
Since its establishment in 1996, the Rivkin Center has been at the forefront of ovarian cancer research. It has provided essential seed-funding grants that have led to groundbreaking discoveries and hosted the biennial Ovarian Cancer Research Symposium in partnership with the American Association of Cancer Research (AACR). Under OCRA's leadership, these signature programs will continue with grants and symposiums renamed to honor Dr. Rivkin's enduring contributions to the field.
Dr. Saul Rivkin, retired oncologist and founder of the Rivkin Center, expressed his confidence in OCRA as an aligned partner to carry forward their vision and amplify their efforts. He believes that this partnership will ensure the growth and success of their investments in research and relationships with the community, bringing them closer to a cure. Dr. Rivkin and his family fully support this exciting new chapter.
More on Washingtoner
- Flexible Plan Investments Names Carl Resnick President
- Tacoma: Statement by Council Member John Hines Celebrating Community Engagement on North Union Avenue Greenway Historic Designation
- Visit Spokane, City of Spokane Partner to Attract Film Production and Drive Economic Development
- Spokane: Public Service Announcement
- Tacoma Police Department Launches Tacoma Public Safety Partnership
Melissa Rivkin, current board president of the Rivkin Center, will join OCRA's Board of Directors, while Dr. Jackie Lang, director of Scientific Programs at the Rivkin Center, will play a crucial role in OCRA's engagement with the scientific community.
OCRA is committed to continuing beloved Rivkin Center initiatives such as the annual SummeRun for Ovarian Cancer, which will take place on July 13, 2025, in Seattle. Dr. Rivkin will be present at the finish line as always.
More details about the combined programs and services will be shared in the coming months. Both OCRA and the Rivkin Center are dedicated to ensuring a seamless transition that honors the legacy of the Rivkin Center while strengthening support for patients, researchers, and the broader ovarian cancer community.
0 Comments
Latest on Washingtoner
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
- Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
- DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
- Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
- Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
- VISION 2050 Award for Historic Tideflats Subarea Plan Presented by Puget Sound Regional Council at Tacoma City Council Meeting
- The Golden Jazz Fest Shuttle Returns for 2026
- City of Tacoma to Activate New Automated Enforcement Cameras Beginning September 14
- KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night
- Covington Makers Market Returns Sept. 12 with Local Makers, Artists, Small Businesses & Food Vendors
- Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
- Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
- 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
- Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
- Hollywood In Pixels Announces Honorees for The 9th Silver PIXel Awards
- New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
- GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
- LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards